EP. 1: Introduction
EP. 2: What Are LDTs and How Are They Regulated?
EP. 3: Payer and Consumer Response to FDA Regulation of LDTs
EP. 4: Justifying the Need for FDA Regulation of LDTs
EP. 5: LDTs and the Political Wheelhouse
EP. 6: Can Academic Innovation in LDTs Be Halted?
EP. 7: What Are the Constructs of Value-Based Care?
EP. 8: Implications of Bundled Payments in Oncology
EP. 9: Bundled Payments in Oncology: What Do Payers Think?
EP. 10: Drug Prices and Patient Burden in Oncology
EP. 11: Oral Parity Laws and Patient Cost Sharing
EP. 12: Can Indication-Based Pricing Be a Reality?
EP. 13: Performance-Based Contracting in Oncology
EP. 14: The Path to Site Neutrality
EP. 15: Disparity in Site of Care Costs and Patient Burden
EP. 16: Are Patients Aware of Site of Care Differentials?
EP. 17: Closing Statements
2 Clarke Drive Cranbury, NJ 08512